ReviewFrontiers in artificial intelligence2026
Applications of artificial intelligence in postoperative surveillance and management of esophageal squamous cell carcinoma.
Review in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal squamous cell carcinoma (ESCC) has high risks of postoperative recurrence, complications, and prolonged nutritional and functional recovery, while conventional follow-up (scheduled visits with imaging, endoscopy, and laboratory testing) is often limited by delays and resource constraints. This review summarizes recent applications of artificial intelligence (AI) across perioperative ESCC care, with emphasis on postoperative surveillance and management. Following PubMed/MEDLINE, etc. were searched (inception-2025) for English-language studies using machine learning, deep learning, radiomics, natural language processing (NLP), and digital health algorithms in postoperative monitoring, recurrence prediction, complication warning, and remote follow-up. Evidence indicates that AI-enabled multimodal models integrating electronic health records, imaging radiomics, and biomarkers can predict major complications (e.g., anastomotic leak and pneumonia) with improved timeliness, enabling earlier intervention compared with symptom-triggered workflows. Imaging-driven radiomics combined with machine learning demonstrates robust performance for recurrence risk and recurrence-pattern prediction, supporting refined risk stratification beyond TNM staging and informing individualized surveillance intensity and adjuvant decision-making. Explainable approaches (e.g., SHAP) enhance clinical interpretability by identifying key predictors such as nutritional and inflammatory indices. Intelligent follow-up systems incorporating NLP, wearable sensors, and electronic patient-reported outcomes (ePROs) facilitate closed-loop monitoring, improve early issue detection, and strengthen patient-clinician communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.